13F-HR filed by Fairmount Funds Management LLC
Fairmount Funds Management LLC filed this 13F-HR for the quarter ended 2021-06-30, filed 2021-08-13, with 19 holding rows worth $243,235,000.
- Accession
- 0001802528-21-000007
- Filer
- CIK 1802528
- Filed
- 2021-08-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2021
A holdings report, 19 entries on the cover page, a total value of $243,235,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $243,235,000 with VALUE read as thousands by filing date, 13F file number 028-19908. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| INSMED INC COM PAR $.01 | 457669307 | Stock | 1,283,887 | $36,539,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 1,970,259 | $34,046,000 | thousands by filing date | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 312,598 | $21,088,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 69,144 | $20,817,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 505,890 | $13,163,000 | thousands by filing date | |
| Instil Bio, Inc. | 45783C101 | Common Stock | 673,905 | $13,020,000 | thousands by filing date | |
| ALLAKOS INC | 01671P100 | COM | 152,162 | $12,990,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 1,558,975 | $12,643,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 2,533,237 | $11,096,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 423,817 | $10,337,000 | thousands by filing date | |
| THERAPEUTICS ACQUISITION COR | 88339T103 | COM CL A | 864,214 | $8,875,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 896,281 | $8,694,000 | thousands by filing date | |
| CATABASIS PHARMACEUTICALS IN | 14875P206 | COM NEW | 4,092,166 | $8,634,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 888,980 | $8,570,000 | thousands by filing date | |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 178,058 | $7,836,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 210,000 | $7,354,000 | thousands by filing date | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 149,333 | $6,342,000 | thousands by filing date | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 35,092 | $642,000 | thousands by filing date | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 83,944 | $549,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001802528-21-000007 | this filing | 2021-08-13 | acceptance time not in the bulk data set |